|
A new path to hope
Brainsgate is a medical device company committed to developing a novel treatment modality, electrical SPG stimulation. This platform technology has been shown to increase blood flow to the brain and as a result has broad potential for treating central nervous system disorders. BrainsGate is currently focusing on:
1. Improve the outcome of patients suffering from ischemic stroke, in a 24 hour window after onset of symptoms. 2. Long-term SPG stimulation for the treatment of vascular dementia patients.
 |
Focus: the spheno-palatine ganglion
Two small nervous centers located above the roof of the mouth near the sinuses
read more |
 |
Focus: Stroke
The leading cause of adult long-term disability and the third leading cause of death
read more |
|
August 28, 2009
World Innovation Summit
BrainsGate invited to speak at the third World Innovation Summit in Tel Aviv, September 14. > full story
August 19, 2009
Nordic Stroke 2009
BrainsGate sponsors the 15th Nordic Congress on Cerebrovascular Diseases, 19-22 August 2009, Helsinki, Finland > full story
|